Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 19 and 80 years old
- People whose liver is functioning at a level that doctors classify as "Child-Pugh class A," meaning the liver is still working reasonably well (confirm with trial site)
- People with a physical fitness and activity level that falls within a range doctors describe as ECOG 0-1, meaning they are either fully active or have only minor limitations in daily activities (confirm with trial site)
- People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer) either through clinical assessment or confirmed by a tissue biopsy
- People whose liver cancer is at an advanced stage and cannot be removed by surgery
- People whose cancer is a suitable size and location for radiation therapy, and whose healthy organs can be protected within safe radiation dose limits
Who may not be able to join:
- People whose cancer has spread to the brain
- People who have had another type of cancer within the last 5 years, unless it was a very low-risk cancer such as certain treated cervical, skin, prostate, or uterine cancers
- People who have untreated swollen veins in the stomach or food pipe (varices) that carry a high risk of bleeding
- People with serious medical conditions that are not well controlled
- People who have previously had a liver transplant
- People who have an autoimmune liver disease, where the immune system attacks the liver
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Hwakyung BYUN, Phd, Severance Hospital
Phone: 007981072098955
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progression-free survival at 6 month
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.